Results of FDG-PET scanning in the pre-operative staging of broncho-pulmonary tumours;Résultats de la TEP [18F]-FDG dans la stadification préopératoire des tumeurs pulmonaires

Revue des Maladies Respiratoires

Volumn 22, Issue 4, 2005, Pages 579-585

  Perrotin, C ^a,c   Lemeunier, P ^a   Grahek, D ^b   Molina, T ^a   Petino, A ^a   Alifano, M ^a   Bellenot, F ^a   Magdeleinat, P ^a   Talbot, J N ^b   Regnard, J F ^a  

^a HÔTEL DIEU   (France)

^b HÔPITAL TENON   (France)

^c Service de Chirurgie Thoracique   (France)

Author keywords

Diagnosis; FDG PET; Lung tumour; Thoracic surgery

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER SIZE; CANCER STAGING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; LUNG NODULE; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE CARE; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 25844447859     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1019/200530050     Document Type: Article

References (26)

1. Lowe VJ, Naunheim KS: Positron emission tomography in lung cancer. Ann Thorac Surg 1998; 65: 1821-9.
2. Lowe VJ, Fletcher JW, Gobar L, Lawson M, Kirchner P, Valk P, Karis J, Hubner K, Delbeke D, Heiberg EV, Patz EF, Coleman RE: Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol 1998; 16: 1075-84.
3. Pieterman RM, Van Putten JW, Meuzelaar JJ, Mooyaart EL, Vaalburg W, Koeter GH, Fidler V, Pruim J, Groen HJ: Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 2000; 343: 254-61.
4. Gupta NC, Tamim WJ, Graeber GG, Bishop HA, Hobbs GR: Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging. Chest 2001; 120: 521-7.
5. Kernstine KH, McLaughlin KA, Menda Y, Rossi NP, Kahn DJ, Bushnell DL, Graham MM, Brown CK, Madsen MT: Can FDG-PET reduce the need for mediastinoscopy in potentially resectable non small cell lung cancer? Ann Thorac Surg 2002; 73: 394-401.
6. Bourguet P, Blanc-Vincent MP, Boneu A, Bosquet L, Chauffert B, Corone C, Courbon F, Devillers A, Foehrenbach H, Lumbroso JD, Mazselin P, Montravers F, Moretti JL, Talbot JN: FNCLCC PET-Scanning Committee: Summary of the Standards, Options and Recommendations for the use of positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose (FDP-PET scanning) in oncology (2002). Br J Cancer 2003; 89: S84-91.
7. Reed CE, Harpole DH, Posther KE, Woolson SL, Downey RJ, Meyers BF, Heelan RT, MacApinlac HA, Jung SH, Silvestri GA, Siegel BA, Rusch VW: American College of Surgeons Oncology Group Z0050 trial: Results of the american college of surgeons oncology group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J Thorac Cardiovasc Surg 2003; 126: 1943-51.
8. Gonzalez-Stawinski GV, Lemaire A, Merchant F, O'Halloran E, Coleman RE, Harpole DH, D'Amico TA: A comparative analysis of positron emission tomography and mediastinoscopy in staging non-small cell lung cancer J Thorac Cardiovasc Surg 2003; 126: 1900-5.
9. Gould MK, Maclean CC, Kuschner WG, Rydzak CE, Owens DK: Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 2001; 285: 914-24.
10. Gambhir SS, Czernin J, Schwimmer J, Silverman DH, Coleman RE, Phelps ME: A tabulated summary of the FDG PET literature. J Nucl Med 2001; 42: 1S-93S.
11. Luke WP, Pearson FG, Todd TR, Patterson GA, Cooper JD: Prospective evaluation of mediastinoscopy for assessment of carcinoma of the lung. J Thorac Cardiovasc Surg 1986; 91: 53-6.
12. Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, von Schulthess GK, Steinert HC: Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003; 348: 2500-7.
13. Dwamena BA, Sonnad SS, Angobaldo JO, Wahl RL: Metastases from non-small cell lung cancer: mediastinal staging in the 1990s-meta-analytic comparison of PET and CT. Radiology 1999; 213: 530-6.
14. Hellwig D, Ukena D, Paulsen F, Bamberg M, Kirsch CM: Onko-PET der Deutschen Gesellschaft fur Nuklearmedizin. [Meta-analysis of the efficacy of positron emission tomography with F-18-fluorodeoxyglucose in lung tumors. Basis for discussion of the German Consensus Conference on PET in Oncology 2000] Pneumologie 2001; 55: 367-77.
15. Gould MK, Kuschner WG, Rydzak CE, Maclean CC, Demas AN, Shigemitsu H, Chan JK, Owens DK: Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. Ann Intern Med 2003; 139: 879-92.
16. Toloza EM, Harpole L, McCrory DC: Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest 2003; 123: 137S-146S.
17. Vansteenkiste JF, Stroobants SG, Dupont PJ, De Leyn PR, De Wever WF, Verbeken EK, Nuyts JL, Maes FP, Bogaert JG: FDG-PET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases? The Leuven Lung Cancer Group. Eur J Nucl Med 1998; 25: 1495-501.
18. Graeter TP, Hellwig D, Hoffmann K, Ukena D, Kirsch CM, Schafers HJ: Mediastinal lymph node staging in suspected lung cancer: comparison of positron emission tomography with F-18-fluorodeoxyglucose and mediastinoscopy. Ann Thorac Surg 2003; 75: 231-5.
19. Kernstine KH, McLaughlin KA, Menda Y, Rossi NP, Kahn DJ, Bushnell DL, Graham MM, Brown CK, Madsen MT: Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer? Ann Thorac Surg 2002; 73: 394-40.
20. Pfister DG, Johnson DH, Azzoli CG, Sause W, Smith TJ, Baker S Jr, Olak J, Stover D, Strawn JR, Turrisi AT, Somerfield MR: American Society of Clinical Oncology: American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003 J Clin Oncol 2004; 22: 330-53.
21. Erasmus JJ, Patz EF Jr, McAdams HP, Murray JG, Herndon J, Coleman RE, Goodman PC: Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. AJR 1997; 168: 1357-60.
22. Maurea S, Klain M, Mainolfi C, Ziviello M, Salvatore M: The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal mass. J Nucl Med 2001; 42: 884-92.
23. Copeland PM: The incidentally discovered adrenal mass. Ann Intern med 1983; 98: 940-5.
24. Swensen SJ, Jett JR, Hartman TE, Midthun DE, Sloan JA, Syke AM, Aughenbaugh GL, Clemens MA: Lung cancer screening with CT: Mayo Clinic experience. Radiology 2003; 226: 756-61.
25. Berquist TH, Bailey PB, Cortese DA, Miller WE: Transthoracic needle biopsy: accuracy and complications in relation to location and type of lesion. Mayo Clin Proc 1980; 55: 475-81.
26. Pastorino U, Veronesi G, Landoni C, Leon M, Picchio M, Solli PG, Leo F, Spaggiari L, Pelosi G, Bellomi M, Fazio F: Fluorodeoxyglucose positron emission tomography improves preoperative staging of resectable lung metastasis. J Thorac Cardiovasc Surg 2003; 126: 1906-10.